Ronovo Surgical's $67M Boost & Eli Lilly's AI Leap in Drug Discovery - Life AI Weekly #33

Hi there,

Welcome to this week's edition of Life AI Weekly, where we delve into the latest advancements in Healthcare & Life Sciences AI. This week, we explore how Hoth Therapeutics is leveraging Lantern Pharma's AI platform to enhance drug discovery processes. Meanwhile, myTomorrows is actively referring Duchenne patients to clinical trials, showcasing the growing role of AI in patient care and trial matching.

In other news, Eli Lilly has launched a new AI platform aimed at accelerating drug discovery, and Anju Software has introduced an AI ecosystem designed to optimize clinical trials. These developments highlight the increasing integration of AI technologies in healthcare, promising more efficient and effective solutions for patient treatment and drug development.

Ketryx has raised $39 million in Series B funding led by Transformation Capital to enhance its AI compliance platform for life sciences. Meanwhile, Ronovo Surgical secured $67 million in Series D funding from Johnson & Johnson's venture capital arm to commercialize its Carina surgical robot in China and expand globally.

Hoth Therapeutics is leveraging Lantern Pharma's PredictBBB.ai platform to enhance drug development by accurately predicting blood-brain barrier permeability. Meanwhile, myTomorrows has referred 611 Duchenne muscular dystrophy patients to clinical trials, with nearly 300 enrolled globally, utilizing AI to improve access to pre-approval treatments for rare diseases.

MIT has made significant strides in AI with the development of two innovative tools. The FlowER system predicts chemical reactions while adhering to physical constraints, enhancing fields such as medicinal chemistry. Additionally, VaxSeer improves flu vaccine predictions, often surpassing the accuracy of the WHO's selections.

Dr. Eunho Lee from Seoul National University of Science and Technology has developed organic materials to improve artificial synapses for AI chips. Researchers at SEOULTECH have created hybrid microelectrode arrays for safer brain-computer interfaces. LenioBio GmbH and AffinityAI have partnered to enhance protein discovery and optimization. SOPHiA GENETICS has teamed up with Jessa Ziekenhuis to advance cancer care through genomic testing. Gilead Sciences has started building an AI-enabled manufacturing hub in California to boost biologics capabilities.

Acer Medical has launched aiMed, a generative AI system designed to streamline medical documentation by converting voice or typed notes into structured electronic records. Meanwhile, WRLDS Technologies has unveiled the 6th SENSE, an AI-driven wearable aimed at real-time health monitoring for military and emergency personnel, currently being tested by armed forces and law enforcement in various countries.